Marine compounds for the therapeutic treatment of neurological disorders

被引：26

作者：

Alonso, D ^{[1
]}

Castro, A ^{[1
]}

Martinez, A ^{[1
]}

机构：

[1] Neuropharma SA, Madrid 28760, Spain

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 2005年 / 15卷 / 10期

关键词：

Alzheimer's disease; marine natural product; neuroinflammation; neuropathic pain;

D O I：

10.1517/13543776.15.10.1377

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

The marine environment has proven to be a very rich source of extremely potent compounds that demonstrate significant biological activities. in general, recently published literature reviews organise the marine compound patents phylogenetically. However, this review focuses on the potential of marine natural compounds as a source for new drugs to treat neurological disorders. Patents covering the period 1998-2004 are examined and two pathologies arise with success in this area: Alzheimer's disease and neuropathic pain, which will be the focus of this review.

引用

页码：1377 / 1386

页数：10

共 65 条

[1]

Oxidative signalling and inflammatory pathways in Alzheimer's disease [J].

Anderson, I ;

Adinolfi, C ;

Doctrow, S ;

Huffman, K ;

Joy, KA ;

Malfroy, B ;

Soden, P ;

Rupniak, HT ;

Barnes, JC .

NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE, 2001, 67 :141-149

[2]

[Anonymous], [No title captured]

[3]

Bayer TA, 2001, BRAIN PATHOL, V11, P1

[4]

BREWER S, 2000, CHEM SOC SPEC PUB, V257, P59

[5]

Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81

[6]

CAMBRIDGE BIOTECH LT, 2004, Patent No. 02396108

[7]

Oxidative stress and Alzheimer disease [J].

Christen, Y .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (02) :621S-629S

[8]

COGNETIX INC, 1998, Patent No. 9803541

[9]

Colton CA, 2000, ANN NY ACAD SCI, V899, P292

[10]

CTR NATL RECHERCHE S, 2001, Patent No. 01041768

← 1 2 3 4 5 6 7 →